NCT ID | NCT02053376 |
Title | A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | no |
Sponsors | University of Pittsburgh |
Indications | |
Therapies | |
Age Groups: | adult |